Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline updateJulia Bohlius, Alejandro Lazo‐Langner, Kari Bohlke et al.|Blood Advances|2019Cited by 165
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline UpdateJulia Bohlius, Alejandro Lazo‐Langner, Kari Bohlke et al.|Journal of Clinical Oncology|2019Cited by 152
Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or LymphomaImmacolata Attolico, Attilio Olivieri, Vincenzo Pavone et al.|Transplantation and Cellular Therapy|2011Cited by 74
Breast cancer circulating biomarkers: advantages, drawbacks, and new insightsDaniele Generali, Andrea Ravelli, Francesco Lanza et al.|Tumor Biology|2015Cited by 47
CART-Cell Therapy: Recent Advances and New Evidence in Multiple MyelomaMassimo Martino, Claudio Cerchione, Filippo Antonio Canale et al.|Cancers|2021Cited by 38